Loading insider details...
Latest Form 4 (Jun 11, 2026): Grant/Award of 70,000 ALDX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 70,000 | n/a |
| Feb 6, 2026 | Aclaris Therapeutics, Inc. (ACRS) | Grant/Award | 274,800 | n/a |
| Feb 5, 2026 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 63,475 | n/a |
| Jan 5, 2026 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 29,150 | n/a |
| Jun 12, 2025 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 62,728 | n/a |
| May 5, 2025 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 9,467 | n/a |
| Apr 3, 2025 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 9,467 | n/a |
| Mar 4, 2025 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 9,466 | n/a |
| Feb 4, 2025 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 9,467 | n/a |
| Jan 3, 2025 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 9,467 | n/a |